Tweet #379890898953175040
Lumenis Receives FDA Clearance for ResurFX, New Fractional Non-Ablative Module for M22 Aesthetic Platform firstwordmedtech.com/node/957812 @LumenisInc
Lumenis Receives FDA Clearance for ResurFX, New Fractional Non-Ablative Module for M22 Aesthetic Platform firstwordmedtech.com/node/957812 @LumenisInc